Clinical manifestations
•Cholera is an extremely virulent disease that can cause severe acute watery diarrhea
•Cholera toxin is multimeric protein of 84000 Da
•It is composed of two major regions
•Region A(28000 Da) : responsible for biological activity of enterotoxin
•Region B(56000 Da) : composed of 5 identical non covalently associated peptide
chain of 11500 Da
•The two region are non covalently bounded
•The A subunit require nicking by protease to activate it and it is made up of two
peptide linked by a single disulphidebridge
•Incubation period is 1-4 days
Strategies for drug therapy of cholera
Previous TU Question
What is the drug of choice and mechanism of action for the treatment of vibrio cholerae ? (2076, 2074)
•Cholera toxin, released from the bacterium Vibrio cholerae, consists of an ‘A’
subunit coupled to a ‘B’ subunit that contains five identical peptides assembled in
a pentameric ring.
•Cholera toxin binds to intestinal enterocytes through interaction of the B subunit
with the GM1 ganglioside receptor. It is then internalized through retrograde
endocytosis.
•The internalized A subunit causes constitutive activation of adenylyl cyclase
(AC),
resulting in elevated levels of intracellular cAMP , which causes active secretion
of salt and fluid through activation of the cystic fibrosis transmembrane
conductance regulator (CFTR) ClKchannel in the apical plasma membrane of
enterocytes, in addition to inhibition of electroneutral Na absorption .
Prevention of diarrhea in cholera can be achieved by :
(a) elimination of V. cholera bacteria through host immunity and/or antibiotics;
(b) inhibition of cholera toxin binding to intestinal epithelial cells;
(c) inhibition of increased cAMP levels by the action of enkephalins on opioid
receptors; and
(d) inhibition of ClKsecretion by CFTR ClKchannels.
•These targets include determinants of its virulence factor expression and motility.
ToxTgene is a transcriptional activator that induces expression of two important
virulence factors, CT and toxin-coregulated pilus (TCP).
•Virstatinand capsaicinwere identified as inhibitors of Vibrio cholerae virulence
factor expression. Virstatininhibits ToxTdimerization, which is a process required
for ToxTtranscription activation of genes encoded for CT and TCP.
•Capsaicinreduces CT and TCP expression by suppressing the expression of ToxT.
•High-throughput screening identified quinazoline-2,4-diaminoanalog as an
inhibitor of V. cholerae motility.
Targeting bacterial virulence and motility
Other lab finding
•Dehydration leads to high blood urea
•WBC will be high due to hemoconcentration
•It lead to metabolic acidosis with wide anion gap
Alkaline bile salt agar
•Thiosulphate citrate bile salt agar v. Cholerae o1 &
0139 incubate at 37 degree for 24 hours
•Visualization by dark field or phase microscopy
•Gram stain : red curved rods bacteria
•Isolation v. cholerae from patients stools
•Yellow colonies on thiosulphate bile salt sucrose
Molecular test
•PCR
Treatments
Eg: Tetracyclines
Glucose + salt+ water
Eg: dukoral